Sirolimus- versus Paclitaxel-Eluting stents for the treatment of cardiac allograft vasculopathy

JACC: Cardiovascular Interventions

Volumn 3, Issue 4, 2010, Pages 378-382

  Lee, Michael S ^a   Tarantini, Giuseppe ^b   Xhaxho, Jola ^b   Yang, Tae ^a   Ehdaie, Ashkan ^a   Bhatia, Ravi ^a   Favaretto, Enrico ^b   Tobis, Jonathan ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

coronary artery vasculopathy; drug eluting stent; heart transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLYCERYL TRINITRATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; PREDNISONE; RAPAMYCIN; TACROLIMUS; CARDIOVASCULAR AGENT;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; STENT THROMBOSIS; TREATMENT OUTCOME; VASOSPASM; AGED; ALLOTRANSPLANTATION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; HEART TRANSPLANTATION; HOSPITALIZATION; INSTRUMENTATION; ITALY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSTHESIS; RADIOGRAPHY; RETROSPECTIVE STUDY; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HEART TRANSPLANTATION; HUMANS; ITALY; LOS ANGELES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIROLIMUS; THROMBOSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77954667904     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.02.005     Document Type: Article

References (22)

1. D.O. Taylor, L.B. Edwards, and M.M. Boucek Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report2007 J Heart Lung Transplant 26 2007 769 781
2. M.R. Costanzo, D.C. Naftel, and M.R. Pritzker Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors Cardiac Transplant Research Database J Heart Lung Transplant 17 1998 744 753
3. S.Z. Gao, J.S. Schroeder, S. Hunt, and E.B. Stinson Retransplantation for severe accelerated coronary artery disease in heart transplant recipients Am J Cardiol 62 1988 876 881
4. A.A. Halle, G. DiSciascio, and E.K. Massin Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients J Am Coll Cardiol 26 1995 120 128
5. M. Musci, M. Pasic, and R. Meyer Coronary artery bypass grafting after orthotopic heart transplantation Eur J Cardiothorac Surg 16 1999 163 168
6. M.S. Lee, J. Kobashigawa, and J. Tobis Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy J Am Coll Cardiol Intv 1 2008 710 715
7. A. Gupta, D. Mancini, and A.J. Kirtane Value of drug-eluting stents in cardiac transplant recipients Am J Cardiol 103 2009 659 662
8. S.A. Hunt, and F. Haddad The changing face of heart transplantation J Am Coll Cardiol 52 2008 587 598
9. B.F. Uretsky, S. Murali, and P.S. Reddy Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone Circulation 76 1987 827 834
10. H. Tsutsui, K.M. Ziada, and P. Schoenhagen Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study Circulation 104 2001 653 657
11. H. Valantine Cardiac allograft vasculopathy after heart transplantation: risk factors and management J Heart Lung Transplant 23 2004 S187 S193
12. B. Radovancevic, S. Poindexter, and S. Birovljev Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients Eur J Cardiothorac Surg 4 1990 309 312
13. T. Zerbe, B. Uretsky, and R. Kormos Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen J Heart Lung Transplant 11 1992 S104 S110
14. J.W. Park, M. Merz, P. Barun, and M. Vermeltfoort Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation J Heart Lung Transplant 15 1996 572 579
15. P.J. Michaels, M.L. Espejo, and J. Kobashigawa Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transplant 22 2003 58 69
16. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
17. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
18. M.C. Morice, P.W. Serruys, J.E. Sousa RAVEL Study Group Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
19. A. Schmig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
20. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
21. E. Raichlin, J.H. Bae, and Z. Khalpey Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation Circulation 116 2007 2726 2733
22. J. Hausleiter, A. Kastrati, J. Mehilli OSIRIS Investigators Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial Circulation 110 2004 790 795